Ann: Trading Halt, page-32

Interesting how this coincided directly after the termination of the agreement w/ ONE Championship with reasoning as that the strategic direction of both of our companies have clearly diverged.

IMO this is a strategic raise but as to what we are yet to know.
I also presume that Dr Sud was one of the individuals who pushed for this, and of course remember that CannVaLate and the Med Board would have their holdings diluted as well by this raise and they would all have to be ok with it.

The question is for what strategic purpose does this raise serve?
Its not because we are low on cash, we have enough to last a year.

This is also stated to be a substantial raise so I presume it is larger than the previous 1.95M raise.
Very interested to see how much the raise is, at what price, who it goes to and for what purpose.

Last time it went to Top 20 incl Directors, 1.95M at 3.8c when the SP was 4c and the purpose was perhaps to fund IHLs commitments to the CannVaLate trials (capped at 10%) and the launch of Incannex and the oils.

Look where we are now. I would assume that this raise is at least as good in those terms, I hope they surprise us (positively).